StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Wednesday. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
NYSE:CPHI opened at $0.23 on Wednesday. The stock has a 50 day simple moving average of $0.22 and a 200 day simple moving average of $0.28. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.21.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Use the MarketBeat Dividend Calculator
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Investing in the High PE Growth Stocks
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
